• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA 2020 Annual Report of Medical Device & IVD Registrations in China

NMPA 2020 Annual Report of Medical Device & IVD Registrations in China

Thursday, 25 February 2021 / Published in Medical Device, News, NMPA Registration in China

NMPA 2020 Annual Report of Medical Device & IVD Registrations in China

On February 5, 2021, the NMPA (National Medical Products Administration) issued the 2020 Annual Report for Medical Device Registration.

In 2020, the NMPA received a total of 10,579 applications for the initial registration, registration renewals and changes in licensing items of Class III (Domestic and Overseas) and Class II (Overseas) medical devices, increased by 15.6% as compared to 2019. Amongst the 10,579 applications, the NMPA approved a total of 9,849 applications with an increase of 16.3% as compared to 2019. The NMPA handled a total of 1,844 filing applications of imported Class I medical devices, an increase of 33.3% as compared to 2019.

Table 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 2. Percentage Distribution of Three Types of NMPA Approvals

Chart 3. Percentage Distribution of Approvals for Medical Devices and IVDs

Chart 4. NMPA – No. of Registrations and Applications Approved from January 2015 to December 2020

Chart 5. NMPA – No. of New Registrations Approved from January 2020 to December 2020

In 2020, the NMPA approved 1,572 new registrations in total.

The provincial medical product administration (MPAs) authorities approved a total of 29,650 applications of China domestic Class II medical devices, an increase of 74.2% as compared to 2019.

The municipal medical product administration (MPAs) authorities handled a total of 34,644 filing applications of China domestic Class I medical devices, an increase of 106.8% as compared to 2019.

The top five class II and III product groups of foreign origin to be registered in 2020 were:

1. Dental Instruments
2. Medical Imaging Equipment
3. Passive Implants Devices
4. Neurological and Cardiovascular Surgical Instruments
5. Ophthalmic Devices

The United States of America, Germany, Japan, Korea and Switzerland continue to have the highest number of initial registrations for overseas medical devices as last year, taking up to 72.3% of the total number of initial registrations for overseas medical devices.

List of Top 10 Countries – Exporting Medical Devices to China

  1. USA
  2. Germany
  3. Japan
  4. South Korea
  5. Switzerland
  6. Taiwan
  7. France
  8. Sweden
  9. Netherland
  10. Israel

Fast-track Approval for Medical Devices

NMPA received 197 applications for special review and approval of innovative medical devices and 22 applications for priority review. A total of 26 domestic medical devices have obtained the special approval to market as innovative medical devices in 2020.

From 2014 to 2020, the NMPA approved a total of 95 domestic innovative medical devices (78 local brands) and 4 foreign innovative medical devices (4 global brands).

Further information concerning this topic can be obtained from:
Cisema (Hong Kong) Limited
Tel.: +852 3462 2483
info@cisema.com
www.cisema.com/en

Tagged under: IVDs, NMPA Annual Report

What you can read next

contract manufacturing of Hong Kong medical device and drug in GBA
Contract manufacturing of Hong Kong medical device and drug in GBA supported by China NMPA
Advertisement of Life Science Products
cosmetic ingredient safety information
China’s cosmetic ingredient safety information requirements have been updated

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP